サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：角膜インプラントの世界市場2023-2030
市場調査レポート
商品コード
1296887

角膜インプラントの世界市場2023-2030

Global Corneal Implants Market 2023-2030
出版日: | 発行: Orion Market Research | ページ情報: 英文 135 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
角膜インプラントの世界市場2023-2030
出版日: 2023年05月26日
発行: Orion Market Research
ページ情報: 英文 135 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の角膜インプラント市場は、予測期間中にCAGR 6.3%で成長すると予想されています。この市場は、角膜ドナーの不足とともに角膜失明の発生率が上昇していることに起因して成長しています。角膜移植手術の成長を促進するもう1つの要因は、角膜移植を必要とする高齢化人口の増加です。アメリカのアイバンク協会によると、2018年にアメリカだけで約85,411件の角膜移植が行われました。一方、手術の高価格は市場の成長を抑制するため、この手術の採用は新興諸国ではかなり低く、これも予測期間中の市場の成長を抑止します。

角膜インプラントは、目の角膜を角膜組織で置き換える外科手術で使用されます。角膜インプラントの世界市場を抑制する主な要因としては、人間の眼が、同種プラスチックでできた人工角膜を拒絶する確率が高まることが挙げられます。さらに、世界中で約1000万人が角膜失明に苦しんでいます。このように、角膜失明の発生率の上昇と人間の角膜ドナーの不足は、予測期間中の角膜インプラント市場の成長を促進する主な要因の一つです。

セグメント別の展望

注目すべきシェアを占める人工角膜セグメント

種類別に見ると、人工角膜セグメントは世界の角膜インプラント市場で注目すべきシェアを記録しています。これは、眼疾患に関連する症例の増加に起因しています。市場に大きく貢献している要因は、世界中の角膜ドナーの減少とともに、眼球と組織バンクの不足です。合成角膜インプラントと生体合成角膜インプラントは、人工角膜インプラントの最も一般的な2つのタイプです。一方、人工角膜分野の課題要因は、高い移植費用と、長期にわたって講じなければならない余分な予防措置です。

地域別展望

北米地域が角膜インプラントの世界市場で大きなシェアを占めると予想される

これらの地域の中で、北米地域は予測期間中、角膜インプラント市場で大きなシェアを占めると予測されています。同地域における角膜インプラント市場の成長は、主に同地域における目に関連する問題や視力問題の増加といった要因によってもたらされます。米国アイバンク協会によると、同バンクは2018年に68,102人のドナーから約133,576件の総組織回収を報告しました。したがって、このような数の眼球移植が市場成長の機会をもたらすと考えられます。さらに、同地域のヘルスケアインフラの改善とともに製品の頻繁な開拓が、同地域全体の角膜インプラント市場の成長に寄与しています。

目次

第1章 レポート概要

  • 業界の現状分析と成長ポテンシャルの展望
  • 調査方法とツール
  • 市場内訳
    • セグメント別
    • 地域別

第2章 市場概要と洞察

  • 調査範囲
  • アナリストの洞察と現在の市場動向
    • 主な調査結果
    • 推奨事項
    • 結論

第3章 競合情勢

  • 主要企業分析
  • 主要戦略分析

第4章 市場セグメンテーション

  • 角膜インプラントの世界市場：組織タイプ別
    • 人工角膜
    • ドナー（ヒト）
  • 角膜インプラントの世界市場：角膜疾患別
    • 真菌性角膜炎
    • フックス角膜ジストロフィー
    • 円錐角膜
  • 角膜インプラントの世界市場：エンドユーザー別
    • 病院
    • 眼科クリニック
    • 外来手術センター（ASC）

第5章 地域別分析

  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • イタリア
    • スペイン
    • フランス
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 世界のその他の地域

第6章 企業プロファイル

  • AcuFocus, Inc.
  • Addition Technology, Inc.,（A Company of AJL Ophthalmic, S.A.）
  • Adverum Biotechnologies Inc.
  • Alcon（A Division of Novartis AG）
  • Astellas Pharma US, Inc.
  • Bausch & Lomb Inc.
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Cornea Bioscience
  • CryoLife Inc.
  • F. Hoffmann-La Roche Ltd.
  • Keramed Inc.
  • Medtronic Plc
  • Pfizer Inc.
  • Presbia PLC
図表

LIST OF TABLES

  • 1. GLOBAL CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL ARTIFICIAL CORNEA MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL HUMAN DONOR MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 5. GLOBAL FUNGAL KERATITIS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL FUCHS DYSTROPHY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL KERATOCONUS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 8. GLOBAL CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 9. GLOBAL CORNEAL IMPLANTS IN HOSPITALS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. GLOBAL CORNEAL IMPLANTS IN EYE CLINICS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 11. GLOBAL CORNEAL IMPLANTS IN ASC MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 12. GLOBAL CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 13. NORTH AMERICAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. NORTH AMERICAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 15. NORTH AMERICAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 16. NORTH AMERICAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 17. EUROPEAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. EUROPEAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 19. EUROPEAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 20. EUROPEAN CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 21. ASIA-PACIFIC CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 22. ASIA-PACIFIC CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 23. ASIA-PACIFIC CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 24. ASIA-PACIFIC CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY TISSUE TYPE, 2022-2030 ($ MILLION)
  • 26. REST OF THE WORLD CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY CORNEAL DISEASE, 2022-2030 ($ MILLION)
  • 27. REST OF THE WORLD CORNEAL IMPLANTS MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CORNEAL IMPLANTS MARKET SHARE BY TISSUE TYPE, 2023 VS 2030 (%)
  • 2. GLOBAL CORNEAL IMPLANTS MARKET SHARE BY CORNEAL DISEASE, 2023 VS 2030 (%)
  • 3. GLOBAL CORNEAL IMPLANTS MARKET SHARE BY END-USER, 2023 VS 2030 (%)
  • 4. GLOBAL CORNEAL IMPLANTS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 5. GLOBAL ARTIFICIAL CORNEA MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 6. GLOBAL HUMAN DONOR MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 7. GLOBAL FUNGAL KERATITIS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 8. GLOBAL FUCHS DYSTROPHY MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 9. GLOBAL KERATOCONUS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 10. GLOBAL CORNEAL IMPLANTS IN HOSPITALS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 11. GLOBAL CORNEAL IMPLANTS IN EYE CLINICS MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 12. GLOBAL CORNEAL IMPLANTS IN ASC MARKET SHARE BY REGION, 2023 VS 2030 (%)
  • 13. US CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. CANADA CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. UK CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. FRANCE CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. GERMANY CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. ITALY CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. SPAIN CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. ROE CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. INDIA CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. CHINA CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. JAPAN CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF THE WORLD CORNEAL IMPLANTS MARKET SIZE, 2022-2030 ($ MILLION)
目次
Product Code: OMR2027338

Global corneal implants market is expected to grow at a CAGR of 6.3% during the forecast period. The market is growing attributed to rising in the incidences of corneal blindness along with the lack of human cornea donors. The other factor that will propel the growth of corneal transplant surgery is the increasing aging population that demands corneal transplants. According to the Eye Bank Association of America, there were approximately 85,411 cornea implants were done alone in America in 2018. Whereas, higher prices of surgeries restrain the market growth, therefore the adoption of this surgery is quite low in developing countries which will also deter the growth of the market over the forecast period.

The corneal implant is used in surgical procedures in which the eye cornea is replaced by corneal tissues. The major factor that can restrain the global cornea implant market includes the increased probability of rejection of artificial cornea made up of alloplastic material by the human eye. In addition, approximately 10 million people across the globe suffer from corneal blindness. Thus, the rise in the incidences of corneal blindness along with the lack of human cornea donors is among the primary factor that fuels the growth of the cornea implant market during the forecast period.

Segmental Outlook

The corneal implant market is sectioned based on tissue type, corneal disease, and end-user. Based on the tissue type, the market is segmented into artificial cornea and human donors. Based on the corneal disease, the market is segmented into fungal keratitis, Fuchs dystrophy, and keratoconus. Based on the end-user, the market is segmented into hospitals, eye clinics, and ambulatory surgical centers (ASC).

Artificial Cornea Segment to Register Notable Share

Based on the type, the artificial cornea segment registers a notable share in the global corneal implant market. This is attributed to increasing cases related to eye diseases. The factor that majorly contributes to the market is the shortage of eye and tissue banking along with a decrease in cornea donors across the globe. Synthetic cornea implants and biosynthetic cornea implants are the two most common types of artificial cornea implants. Whereas, the factor that challenges the artificial cornea segment is the high transplantation costs and extra and preventive measures that should be taken for the long term.

Regional Outlooks

The global corneal implants market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East &Africa, and Latin America). The market can be analyzed for a particular region or country level as per the requirement. Among these, the Europe market is anticipated to cater to a prominent growth over the forecast period. However, the Asia-Pacific region is projected to experience considerable growth in the Corneal Implants market.

The North American Region is anticipated to Hold a Significant Share in the Global Corneal Implants Market

Among these regions, the North American region is anticipated to account for a significant share of the Corneal Implants market during the forecast period. The growth of the corneal implants market in the region is primarily driven by factors such as the increased number of eye-related issues and vision problems in the region. According to the Eye Bank Association of America, the bank reported approximately 133,576 total tissue recoveries from 68,102 donors in 2018. Thus, these numbers of eye transplants are likely to provide opportunities for market growth. In addition, the frequent development of the products along with the improved healthcare infrastructure of the region contributes to the growth of the corneal implants market across the region.

Market Players Outlook

The prominent players operating in the global corneal implants market include Bayer AG, Medtronic Plc, F. Hoffmann-La Roche Ltd., Pfizer Inc. Bausch & Lomb Inc., PowerVision Inc., Presbia PLC, Regeneron Pharmaceuticals Inc. among others. These are the key companies providing various solutions for novel and advanced corneal implants. The corneal implant manufacturers are adopting various strategies such as new product launches and approvals, mergers and acquisitions, partnerships and collaborations, and many others to thrive in a competitive environment in the market. For instance, In June 2016, the US FDA approved the Raindrop Near Vision Inlay, for the improvement of near vision is presbyopic. Further, in April 2015, the US FDA approved the Kamra Corneal Inlay, the first small aperture corneal implantable device for the correction of near vision in patients who have not had cataract surgery.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Company
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Corneal Implants Market by Tissue Type
    • 4.1.1. Artificial Cornea
    • 4.1.2. Human Donor
  • 4.2. Global Corneal Implants Market by Corneal Disease
    • 4.2.1. Fungal keratitis
    • 4.2.2. Fuchs Dystrophy
    • 4.2.3. Keratoconus
  • 4.3. Global Corneal Implants Market by End-User
    • 4.3.1. Hospitals
    • 4.3.2. Eye Clinics
    • 4.3.3. Ambulatory Surgical Centers (ASC)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. AcuFocus, Inc.
  • 6.2. Addition Technology, Inc., (A Company of AJL Ophthalmic, S.A.)
  • 6.3. Adverum Biotechnologies Inc.
  • 6.4. Alcon (A Division of Novartis AG)
  • 6.5. Astellas Pharma US, Inc.
  • 6.6. Bausch & Lomb Inc.
  • 6.7. Bayer AG
  • 6.8. Boehringer Ingelheim GmbH
  • 6.9. Cornea Bioscience
  • 6.10. CryoLife Inc.
  • 6.11. F. Hoffmann-La Roche Ltd.
  • 6.12. Keramed Inc.
  • 6.13. Medtronic Plc
  • 6.14. Pfizer Inc.
  • 6.15. Presbia PLC